Kamada (KMDA) Other Non-Current Assets (2012 - 2025)
Kamada (KMDA) reported Other Non-Current Assets of $7.5 million for Q4 2025, down 5.92% on a YoY basis from $8.0 million in Q4 2024, and down 5.92% quarter-over-quarter from $8.0 million in Q4 2024.
Kamada (KMDA) Other Non-Current Assets (2012 - 2025) Analysis & Trends
Kamada has reported Other Non-Current Assets for 14 years, with the latest figure at $7.5 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets fell 5.92% year-over-year to $7.5 million; the trailing twelve-month figure through Dec 2025 stood at $7.5 million (down 5.92% YoY), and the FY2025 full-year result was $7.5 million, down 5.92% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $7.5 million, down from $8.0 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $8.5 million in Q4 2023, with the low at $3.2 million in Q1 2021.
- Historically, Other Non-Current Assets has averaged $5.9 million across 5 years, with a median of $6.6 million in 2021.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets surged 222.59% — and 2025, when it slipped 5.92%.
- Kamada's Other Non-Current Assets stood at $5.6 million in 2021, then surged by 36.25% to $7.6 million in 2022, then gained by 12.12% to $8.5 million in 2023, then slipped by 5.6% to $8.0 million in 2024, then declined by 5.92% to $7.5 million in 2025.
- The last three Other Non-Current Assets figures came in at $7.5 million (Q4 2025), $8.0 million (Q4 2024), and $8.5 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.54 Mn |
| Dec 31, 2024 | 8.02 Mn |
| Dec 31, 2023 | 8.50 Mn |
| Dec 31, 2022 | 7.58 Mn |
| Dec 31, 2021 | 5.56 Mn |
| Sep 30, 2021 | 3.38 Mn |
| Jun 30, 2021 | 3.41 Mn |
| Mar 31, 2021 | 3.18 Mn |
| Dec 31, 2020 | 2.06 Mn |
| Sep 30, 2020 | 1.08 Mn |
| Jun 30, 2020 | 1.06 Mn |
| Mar 31, 2020 | 1.05 Mn |
| Dec 31, 2019 | 352,000.00 |
| Sep 30, 2019 | 178,000.00 |
| Jun 30, 2019 | 174,000.00 |
| Mar 31, 2019 | 174,000.00 |
| Dec 31, 2018 | 174,000.00 |
| Sep 30, 2018 | 176,000.00 |
| Jun 30, 2018 | 173,000.00 |
| Mar 31, 2018 | 173,000.00 |